Results 11 to 20 of about 1,433,283 (333)
RESIDUAL RADIOPAQUE BOLUS IN MANAGING INTRASPINAL NEOPLASMS [PDF]
American Journal of Roentgenology, 1966 Patients with intraspinal tumors often undergo myelographic examination. The subsequent course and response of such patients to radiation therapy can be documented expeditiously by leaving behind a bolus of the contrast agent at the time of the initial study. The technique is described in detail and illustrated with the report of a typical case.
C F, Martin, E, Gedgaudas, G J, D'Angio
openaire +2 more sources
Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches [PDF]
BioMed Research International, 2016 The presence of acquired mutations within theJAK2,CALR,andMPLgenes in the majority of patients with myeloproliferative neoplasms (MPN) affords the opportunity to utilise these mutations as markers of minimal residual disease (MRD). Reduction of the mutated allele burden has been reported in response to a number of therapeutic modalities including ...
Karl Haslam, Stephen E. Langabeer
openaire +3 more sources
Oman Medical Journal, 2021 Objectives: We sought to identify leukemia-associated immunophenotypes (LAIPs) in 50 acute myeloid leukemia (AML) patients at diagnosis using an eight-color multiparameter flow cytometry (MFC) panel and to detect if they showed any alteration in relapsed/
Hadeer Mohamed Rasheed +4 more
doaj +1 more source
Brazilian Journal of Oncology, 2021 Objective: Breast cancer is the most common malignancy among women, both in developed and in developing countries. Indications for neoadjuvant treatment have been expanded so that pathological responses can be evaluated.
Letícia Morais C. O. Sermoud +6 more
doaj +1 more source
Ожирение и метаболизм, 2022 Acromegaly is a severe neuroendocrine disease caused by chronic excessive production of somatotropic hormone (STH), characterized by specific changes in appearance, metabolic disorders.
L. K. Dzeranova +8 more
doaj +1 more source
Клиническая онкогематология, 2021 A personalized approach is a promising tool for malignant neoplasm (MN) treatment. Gaining success and benefit assessment of this approach were considerably facilitated by the implementation of the new generation sequencing techniques which allow to ...
Aleksandra Vladimirovna Semyanikhina +1 more
doaj +1 more source
Clinical Case Reports, 2020 Primary UPS of the lung, so‐called MFH, is a rare aggressive neoplasm and known to be a high risk of recurrence and metastasis. Surgical resection without residual tumor is the main option of treatment and the best chance for long‐term survival.
Yudai Miyashita +2 more
doaj +1 more source
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
Cancer Management and Research, 2020 Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by the BCR-ABL1 fusion gene generation as a consequence of the t(9;22)(q34;q11) rearrangement.
Cosimo Cumbo +3 more
semanticscholar +1 more source
The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine [PDF]
The Korean Journal of Internal Medicine, 2023 Background/Aims We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy.
Mihee Kim +14 more
doaj +1 more source
Different Body Fluid Biopsies for Detecting Minimal Residual Disease in Lung Cancer: a Review of the Latest Advances [PDF]
Zhongguo quanke yixue, 2023 Post-treatment recurrence is a major difficulty in the treatment of lung cancer, one of the deadliest cancers worldwide. Minimal residual disease (MRD) as a "bridgehead" for the recurrence of solid tumors, is described as the presence of free ...
YAN Xing, LIU Shanmei, LIU Changhong
doaj +1 more source